KD Logo

BLUE’s latest rating updates from top analysts.

Bluebird bio Inc’s recent filing unveils that its President and CEO Obenshain Andrew unloaded Company’s shares for reported $9311.0 on Mar 04 ’24. In the deal valued at $1.53 per share,6,095 shares were sold. As a result of this transaction, Obenshain Andrew now holds 279,998 shares worth roughly $0.26 million.

Then, Klima Thomas J sold 4,573 shares, generating $6,986 in total proceeds. Upon selling the shares at $1.53, the insider now owns 124,840 shares.

Before that, Colvin Richard A sold 6,770 shares. Bluebird bio Inc shares valued at $10,342 were divested by the Chief Medical Officer at a price of $1.53 per share. As a result of the transaction, Colvin Richard A now holds 118,368 shares, worth roughly $0.11 million.

HSBC Securities downgraded its Bluebird bio Inc [BLUE] rating to a Reduce from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in early December from “an Underweight” to “an Equal-weight”. Cantor Fitzgerald began covering BLUE with “Neutral” recommendation on October 17, 2023. HSBC Securities started covering the stock on September 06, 2023. It rated BLUE as “a Buy”.

Price Performance Review of BLUE

On Monday, Bluebird bio Inc [NASDAQ:BLUE] saw its stock jump 0.07% to $0.92. Over the last five days, the stock has lost -3.17%. Bluebird bio Inc shares have fallen nearly -33.09% since the year began. Nevertheless, the stocks have fallen -74.91% over the past one year. While a 52-week high of $5.53 was reached on 02/27/24, a 52-week low of $0.88 was recorded on 02/06/24. SMA at 50 days reached $1.2495, while 200 days put it at $2.4320. A total of 5.64 million shares were traded, compared to the trading of 8.18 million shares in the previous session.

Levels Of Support And Resistance For BLUE Stock

The 24-hour chart illustrates a support level at 0.8950, which if violated will result in even more drops to 0.8665. On the upside, there is a resistance level at 0.9649. A further resistance level may holdings at 1.0063. The Relative Strength Index (RSI) on the 14-day chart is 35.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0813, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.90%. Stochastics %K at 10.45% indicates the stock is a buying.

Most Popular

[the_ad id="945"]